Hydrogen Breath Test Analyzer Market: North America with a share of 37% is the leading regional segment

The global market for hydrogen breath test analyzers was estimated at US$ 26.6 million in 2017 and is expected to reach US$ 37.3 million by 2026, expanding at a CAGR of 3.9% from 2018 to 2026.

Hydrogen breath testing is a highly specific and sensitive diagnostic tool used by gastroenterologists to either confirm or eliminate the possibility of carbohydrate malabsorption or short bacterial overgrowth. As a result of recent technological advances associated with the development of electrochemical and solid state sensors, they are gradually replacing conventional diagnostic methods used earlier to diagnose functional gastrointestinal disorders.

Full Report Available

Portable analyzers dominate the market for hydrogen breath test analyzer type segment. Gastroenterologist popularity and excellent ergonomic design drive market growth for portable analyzers. Handheld analyzers are gaining traction due to their inherent features such as compactness, user-friendly interface and rapid exhaled air analysis.

The sensor segment for the market of hydrogen breath test analyzers is dominated by electrochemical sensors. Recent developments in the generation of breathprints containing chemical markers, high precision and sensitivity and low power consumption are driving market growth for electrochemical sensors. Solid state sensors work on the principle of reaction between the analyte in exhaled air and sensor material is transformed as an electrical signal due to changes in the active element’s potential, conductance or capacitance.

North America is the leading regional segment for the hydrogen breath test analyzer market with a share of 37 percent. The main factors corroborated by its growth in the market are the increasing prevalence of carbohydrate malabsorption and the existence of sophisticated healthcare infrastructure. The domicile of key players such as Healius Limited, Metabolic Solutions, Inc., and MD Diagnostics Ltd. further consolidates market growth in the

North American region. Europe accounts for 33% of the share due to a significant increase in patients diagnosed with short intestinal bacterial overgrowth disorder (SIBO) and strategic collaboration between academic research and manufacturers of medical devices to develop excellent ergonomic features of breath analyzers. Asia Pacific is a 10 percent share and will be the fastest growing market due to a large pool of patients suffering from lactose malabsorption and increased awareness of gastrointestinal disorders in public health.

Medical device manufacturers specializing in manufacturing hydrogen breath test analyzers are

• Bedfont Scientific Ltd.,
• Breathe E-Z Systems, Inc.,
• Commonwealth Diagnostics International, Inc.,
• Healius Limited,
• MD Diagnostics Ltd.,
• LABORIE,
• FAN GmbH,
• Metabolic Solutions, Inc.
• QuinTron Instrument Company, Inc.

Key Market Movements:

• Rising prevalence of functional gastrointestinal disorders such as short intestinal bacterial overgrowth and carbohydrate malabsorption
• Technological advancement in the development of electrochemical sensors to determine the concentration of hydrogen gas in exhaled air
• Strategic collaboration between academic research institutes and medical device manufacturers to develop excellent ergonomic design and operational features related to breath analyzers

Full Report Available